Nicolo Reccardini
Udine, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Exploring the therapeutic landscape of pulmonary hypertension associated with interstitial lung disease, with a focus on idiopathic pulmonary fibrosis: a narrative review.
Journal: Frontiers in pharmacology
Published: April 26, 2026
Effectiveness of Desensitization Therapy for Grasses and Dust Mites on Asthma Exacerbations and Respiratory Function During the Allergy Season: A Pilot Study.
Journal: Journal of clinical medicine
Published: December 25, 2025
Complications Associated with Glucocorticoids Treatment in Critically Ill Patients.
Journal: Seminars in respiratory and critical care medicine
Published: October 08, 2025
Retrospective Observational Study of Nintedanib in Managing Idiopathic and Progressive Pulmonary Fibrosis in Routine Practice.
Journal: Journal of clinical medicine
Published: July 27, 2025
Early C-reactive protein reduction predicts survival in COVID-19 severe pneumonia treated with glucocorticoids.
Journal: BMC pulmonary medicine
Published: March 28, 2025
Cardiac sarcoidosis recurrence post-heart transplant: A critical literature and case report.
Journal: Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Published: February 07, 2025
The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 22, 2025
Safety of Nintedanib in a Patient with Chronic Pulmonary Fibrosis and Kidney Disease.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 04, 2024
Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 24, 2024
Autoantibodies in sarcoidosis: Innocent bystander or promising biomarker for organ involvement?
Journal: Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Published: May 18, 2024
Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 11, 2024
Last Updated: 09/26/2026